Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).
Read time: 1 mins
Last updated:3rd May 2012
This study will assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of successive intravenous (IV) doses of LFG316 in eligible patients with neovascular age-related macular degeneration (AMD)
|Study start date||2012-05-03|